We hypothesized that the observed structural variation breakpoints in MCF7 cells, and observed over-expression of SHCBP1 and ORC6, affect the outcomes of breast cancer patients whose primary tumors are ER-positive. The gene discussed is SHCBP1; the disease is breast cancer.